Karyopharm Therapeutics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2018
Total Assets: $341.2M
Liabilities Breakdown FY2018
Total Liabilities: $158.0M
Asset Breakdown
Total Assets: $341.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $118.0M | 34.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.9M | 1.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $219.3M | 64.3% |
Liabilities Breakdown
Total Liabilities: $158.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.3M | 2.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $153.7M | 97.3% |